Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor
about
Impact of the H275Y and I223V Mutations in the Neuraminidase of the 2009 Pandemic Influenza Virus In Vitro and Evaluating Experimental ReproducibilityDerivation of Cinnamon Blocks Leukocyte Attachment by Interacting with SialosidesRandomized controlled ferret study to assess the direct impact of 2008-09 trivalent inactivated influenza vaccine on A(H1N1)pdm09 disease riskInfluenza neuraminidase operates via a nucleophilic mechanism and can be targeted by covalent inhibitorsOseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferretsCharacterization of a novel mutation in NS1 protein of influenza A virus induced by a chemical substance for the attenuation of pathogenicityIn vitro and in vivo characterization of new swine-origin H1N1 influenza virusesExperimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferretsIncorporation of a proteotyping approach using mass spectrometry for surveillance of influenza virus in cell-cultured strains.Influenza A virus isolation, culture and identificationCharacterization of a large cluster of influenza A(H1N1)pdm09 viruses cross-resistant to oseltamivir and peramivir during the 2013-2014 influenza season in JapanEfficient isolation of Swine influenza viruses by age-targeted specimen collection.6SLN-lipo PGA specifically catches (coats) human influenza virus and synergizes neuraminidase-targeting drugs for human influenza therapeutic potential.Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein.Risk assessment of recent Egyptian H5N1 influenza virusesRecent H3N2 Viruses Have Evolved Specificity for Extended, Branched Human-type Receptors, Conferring Potential for Increased Avidity.Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitorsSerum-Free Suspension Culture of MDCK Cells for Production of Influenza H1N1 VaccinesNeuraminidase inhibitor susceptibility of swine influenza A viruses isolated in Germany between 1981 and 2008.Impact of mutations at residue I223 of the neuraminidase protein on the resistance profile, replication level, and virulence of the 2009 pandemic influenza virusThe H275Y neuraminidase mutation of the pandemic A/H1N1 influenza virus lengthens the eclipse phase and reduces viral output of infected cells, potentially compromising fitness in ferrets.In vitro selection of influenza B viruses with reduced sensitivity to neuraminidase inhibitorsConsequences of resistance: in vitro fitness, in vivo infectivity, and transmissibility of oseltamivir-resistant influenza A viruses.Evaluation of recombinant 2009 pandemic influenza A (H1N1) viruses harboring zanamivir resistance mutations in mice and ferrets.A novel bivalent vaccine based on a PB2-knockout influenza virus protects mice from pandemic H1N1 and highly pathogenic H5N1 virus challenges.A recombinant influenza virus vaccine expressing the F protein of respiratory syncytial virus.Influenza A (H5N1) viruses from pigs, Indonesia.Assessing the in vitro fitness of an oseltamivir-resistant seasonal A/H1N1 influenza strain using a mathematical modelCompetitive fitness of oseltamivir-sensitive and -resistant highly pathogenic H5N1 influenza viruses in a ferret model.Phenotypic and genotypic characterization of influenza virus mutants selected with the sialidase fusion protein DAS181.Pathogenicity of highly pathogenic avian H5N1 influenza A viruses isolated from humans between 2003 and 2008 in northern Vietnam.Heterogeneity of the MDCK cell line and its applicability for influenza virus researchInfluenza A virus encoding secreted Gaussia luciferase as useful tool to analyze viral replication and its inhibition by antiviral compounds and cellular proteins.Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in miceA quantitative comet infection assay for influenza virus.A replication-incompetent PB2-knockout influenza A virus vaccine vector.Identification of Stabilizing Mutations in an H5 Hemagglutinin Influenza Virus Protein.Replication-incompetent influenza A viruses that stably express a foreign geneA Bivalent Vaccine Based on a PB2-Knockout Influenza Virus Protects Mice From Secondary Pneumococcal Pneumonia.Characterization of a porcine intestinal epithelial cell line for influenza virus production
P2860
Q24288661-6130B0F5-6238-4ED2-B92D-D38A04024592Q27304346-26FDCDDA-7BBC-4E3D-BBB6-275E3D3D1629Q27330166-98C6B9C9-12EF-4D0D-AE75-A43DDFF7E503Q27684045-87DF5130-296A-4AB3-A8EE-05F79D4F76E8Q28474889-06D2D5BA-BBBA-47C6-8E82-68BF90341EA9Q28544812-7CF485DD-9421-42B7-9776-B1017883B64DQ29619174-7BE382A9-F321-4407-B822-E892C6E24AE8Q29619972-A157055F-BB8A-4ED0-898A-799014CD19C7Q30355569-2AD85996-24FF-49E8-89CA-E5F9B4C16EF0Q30367880-98B37769-5D16-4382-B00F-E7D59A6ADDBFQ30371865-5957D074-CBFF-43E4-AD9C-03EB5D14ED7CQ30371893-B9583EB3-60EF-4314-8B6D-499AF1EFFB46Q30376631-7215503F-7D6B-4810-B0EE-6713C2229458Q30382312-82905E2B-49CD-426A-B118-79774A2032B1Q30396067-32A1DAF4-81A5-45A7-8745-28E8165955EEQ30396804-03FFF8FB-E47D-4B77-947D-DCB1686A7256Q30397253-5E92932A-18DE-4D9A-8493-502CCD1958F8Q30398889-8FD2392F-A533-4031-9C18-3BC693665534Q30404038-2DD6AAF2-1F47-4CAA-8F35-FD3D43D2D709Q30411116-799D4C81-D325-4594-A342-1506548D2E90Q30419738-BD3F359D-CF4E-41C4-906E-CF3C4BFB67EBQ30425126-E308328F-84F1-4AC9-98D7-B902FF11325DQ30425354-8D2A7871-344C-439F-BFCD-1E5580D7A669Q30426441-AF4CF8C0-6592-49D1-98D8-25994401FF76Q30430275-E530055E-DC6B-4705-9988-1A435E9A8BE4Q33578748-E3D1F1CA-B290-44C6-861D-01648D716DBAQ33704592-7D282EDB-E41A-4EF8-A766-590EA6584A7DQ33859412-575A4EF2-C4E8-422F-B318-73B6C7965DD1Q34046111-69A3787A-8033-4BAD-B78E-0076EC7AD7E7Q34405859-49F9B9CA-CF4D-4232-AE15-178B27BACE4BQ34641895-1DC89E75-B1BC-4728-A821-47BCD514C2D1Q34994947-434601EC-F93A-4560-8A57-E4CB168D6D1FQ35171172-74104503-F07C-49D6-9E30-09020FB8C25CQ35385403-662AF05D-8409-4025-93C2-8B6182A6E515Q35667169-7A49DE63-063A-452D-91B1-447171962ECEQ35868034-29299630-AF85-4F09-8521-1CE57E0B62B9Q35882273-77D8EE25-2B42-4BD3-AF7E-E3F9EB254F1AQ35961330-20D43DE3-1BF0-491E-85F9-A752920005FDQ36306944-8A16C51F-F688-4780-92D5-812EB18B7E4EQ36523997-FC6B6587-ECC2-4B32-82D9-E74A9C2C6000
P2860
Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Enhanced expression of an alph ...... y to a neuraminidase inhibitor
@ast
Enhanced expression of an alph ...... y to a neuraminidase inhibitor
@en
type
label
Enhanced expression of an alph ...... y to a neuraminidase inhibitor
@ast
Enhanced expression of an alph ...... y to a neuraminidase inhibitor
@en
prefLabel
Enhanced expression of an alph ...... y to a neuraminidase inhibitor
@ast
Enhanced expression of an alph ...... y to a neuraminidase inhibitor
@en
P2093
P2860
P1476
Enhanced expression of an alph ...... y to a neuraminidase inhibitor
@en
P2093
Chiharu Kawakami
Hideo Goto
Keiko Mitamura
Norio Sugaya
Shuji Hatakeyama
Yasuo Suzuki
P2860
P304
P356
10.1128/JCM.43.8.4139-4146.2005
P407
P577
2005-08-01T00:00:00Z